Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.55 |
| ▸ | GRPR | P30550 | 1/20 | 0.53 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.52 |
| ▸ | TLR2 | O60603 | 3/20 | 0.52 |
| ▸ | CCKBR | P32239 | 6/20 | 0.52 |
| ▸ | ECE1 | P42892 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 1/20 | 0.51 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31247979 | 0.93 | CCKBR (0.53) | MAGI3RXFP1GRPRIL23RCCKBR | |
| SCHEMBL30342394 | 0.91 | MAGI3 (0.54) | MAGI3RXFP1IL23RTLR2CCKBR | |
| SCHEMBL31182529 | 0.91 | MAGI3 (0.59) | MAGI3RXFP1GRPRIL23RTLR2 | |
| SCHEMBL30265201 | 0.89 | PRMT1 (0.53) | MAGI3RXFP1GRPRIL23RCCKBR | |
| SCHEMBL30082892 | 0.87 | CCKBR (0.59) | IL23RCCKBRECE1GLP1RMUS81 | |
| SCHEMBL29939669 | 0.86 | PRMT1 (0.58) | MAGI3GRPRIL23RCCKBRPRMT1 | |
| SCHEMBL31482983 | 0.86 | MAGI3 (0.60) | MAGI3GRPRIL23RTLR2CCKBR | |
| SCHEMBL31020886 | 0.86 | RXFP1 (0.66) | RXFP1TLR2CCKBRECE1GLP1R | |
| SCHEMBL31683350 | 0.85 | CCKBR (0.65) | IL23RCCKBRGLP1R | |
| SCHEMBL31121632 | 0.85 | CCKBR (0.57) | GRPRCCKBRECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510796-A | Combinations of relaxin and vasopressin analogues for the treatment of renal disorders or conditions | 瑞沃2肾脏公司 | 2024-08-16 | — | — | CN | disclosed |